|Image via Wikipedia; C. difficile|
The warning applies to the following PPIs, both prescription and over-the-counter:
- rabeprazole sodium
- esomeprazole magnesium
The FDA is also reviewing the possible risk of in C. difficile-associated diarrhea in users of another class of acid suppressing medications, the histamine H2 receptor blockers.